IRADIMED CORP Files 8-K with Financial Statements
Ticker: IRMD · Form: 8-K · Filed: May 29, 2025 · CIK: 1325618
Sentiment: neutral
Topics: financial-statements, exhibits, disclosure
Related Tickers: IRMD
TL;DR
IRADIMED CORP filed an 8-K with financial statements and exhibits on 5/29/25.
AI Summary
On May 29, 2025, IRADIMED CORP filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating a routine update or disclosure related to the company's financial status and operations. No specific material events or transactions are detailed in the provided excerpt.
Why It Matters
This filing provides an update on IRADIMED CORP's financial statements and exhibits, which is important for investors to assess the company's financial health and operational status.
Risk Assessment
Risk Level: low — The filing appears to be a routine disclosure of financial statements and exhibits, with no indication of significant negative events or risks.
Key Players & Entities
- IRADIMED CORP (company) — Registrant
- May 29, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- 1025 Willa Springs Dr. (address) — Principal executive offices
- Winter Springs, FL 32708 (address) — Principal executive offices
- 407-677-8022 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing by IRADIMED CORP?
The primary purpose of this 8-K filing by IRADIMED CORP is to report on 'Other Events' and 'Financial Statements and Exhibits' as of May 29, 2025.
When was this 8-K report filed by IRADIMED CORP?
This 8-K report was filed on May 29, 2025.
In which state is IRADIMED CORP incorporated?
IRADIMED CORP is incorporated in Delaware.
What is the principal executive office address for IRADIMED CORP?
The principal executive office address for IRADIMED CORP is 1025 Willa Springs Dr., Winter Springs, FL 32708.
What is the telephone number listed for IRADIMED CORP?
The telephone number listed for IRADIMED CORP is (407) 677-8022.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 29, 2025 regarding IRADIMED CORP (IRMD).